Primary hormonal treatment for early endometrial carcinoma.
Eur J Gynaecol Oncol
; 19(6): 565-8, 1998.
Article
em En
| MEDLINE
| ID: mdl-10215442
Four cases of clinical Stage I endometrial carcinoma initially treated with hormonal therapy are included in this study. Three of them resulted in tumor regression and two of them permitted a subsequent three pregnancies. All patients are alive and without evidence of disease with a median follow-up of 35.7 months (range 17 to 72 months). We believe this is a promising approach through which we may be able to offer a conservative treatment maintaining high survival rates and preserving childbearing potential. Diagnostic and therapeutic data for fertility-desiring patients with endometrial carcinoma are analyzed in this study.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Adenocarcinoma
/
Neoplasias do Endométrio
/
Acetato de Medroxiprogesterona
/
Antineoplásicos Hormonais
Tipo de estudo:
Observational_studies
/
Prognostic_studies
Limite:
Adult
/
Female
/
Humans
Idioma:
En
Ano de publicação:
1998
Tipo de documento:
Article